Investing Ideas
/
Egyptian Pharmaceuticals & Biotech Undervalued Stocks Based On Cash Flows

Egyptian Pharmaceuticals & Biotech Undervalued Stocks Based On Cash Flows

Name: Financial Insights Based on S&P Global Market Intelligence
Creator: Simply Wall St Pty Ltd
License: https://www.spglobal.com/content/dam/spglobal/corporate/en/documents/secure/MI-FastTrack-Terms-and-Conditions-July-2023.pdf

Results

0 new

Companies with promising cash flow potential yet trading below their fair value, as determined by SWS DCF valuation, signaling opportunity for value-oriented investors.

1 companies

	Company	Last Price	7D Return	1Y Return	Market Cap	Analysts Target	Valuation	Growth	Div Yield
	PHAR Egyptian International Pharmaceutical Industries	ج.م44.52	-2.9%	8.6%	ج.م6.7b	ج.م77.62	PE5.7x	E21.7%	2.2%

Page 1 of 1